Download image Noven Pharmaceuticals, Inc. (PRNewsFoto/Noven Pharmaceuticals, Inc.) MIAMI and NEW YORK, March 25, 2014 /PRNewswire/ -- Noven Pharmaceuticals, Inc. today announced the U.S. Patent and Trademark Office has issued U.S. Patent No. 8,658,663, entitled "Method Of Treating Thermoregulatory Dysfunction With Paroxetine." This method of use patent covers the company's Brisdelle® (paroxetine) capsules, 7.5 mg, for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause, commonly referred to as hot flashes. The patent, listed recently in the U.S. Food and Drug Administration (FDA)'s Orange Book, provides additional protection until April 2029, six...
↧
